Context Therapeutics Inc.

NASDAQ: CNTX · Real-Time Price · USD
0.76
0.02 (3.22%)
At close: Aug 15, 2025, 9:58 AM

Context Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-26.73M -23.96M -14.84M -10.46M
Depreciation & Amortization
10.88K 12.04K 9.27K n/a
Stock-Based Compensation
841.87K 1.08M 976.44K 511.08K
Other Working Capital
-2.53M 329.03K 510.37K -1.36M
Other Non-Cash Items
14.79M 51.97K 578.52K 3.37M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-3.48M 1.78M -277.52K -2.22M
Operating Cash Flow
-14.56M -21.05M -13.55M -8.8M
Capital Expenditures
-14.76M n/a -536.84K -250K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-14.75M n/a -500 n/a
Investing Cash Flow
-14.76M n/a -536.84K -250K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -102.07K n/a
Financial Cash Flow
109.29M n/a -102.07K 58.39M
Net Cash Flow
79.98M -21.05M -14.19M 49.34M
Free Cash Flow
-29.31M -21.05M -14.09M -9.05M